COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

PARASITES WITHOUT BORDERS INC

PORT WASHINGTON, NY · EIN 812833673 · Form 990 · FY2023 · NTEE G80 · Voluntary Health Associations · Small ($100K-$1M) · parasiteswithoutborders.com
revenue
$136K
expenses
$304K
net assets
$217K
employees
0
volunteers
5
program ratio
88%
mission · from form 990

PARASITES WITHOUT BORDERS WILL SERVE AS A COMPREHENSIVE, ADVANCED EDUCATIONAL RESOURCE AND DISSEMINATOR OF BASIC AND CLINICAL INFORMATION DEALING WITH ALL ASPECTS OF THE GLOBAL PROBLEM OF PARASITIC DISEASES THAT ADVERSELY AFFECTS PEOPLES AROUND THE WORLD.

profile · synthesized from sources

Parasites Without Borders is a nonprofit educational initiative providing free, advanced resources on parasitic diseases to medical professionals and students globally. It aims to improve understanding and treatment of neglected tropical diseases through textbooks, certification programs, and video courses. The organization emphasizes bridging knowledge gaps for physicians serving in resource-limited settings.

named programs · 4 · from sources

What they call their work

Medical Handbook for Limited Resource Settings
Comprehensive e-learning course and reference guide designed for medical professionals working in areas with limited healthcare infrastructure.
Parasitic Diseases Lectures
45-part video lecture series covering the biology and pathogenesis of protozoan and helminth parasites, available as an e-learning course.
Tropical Medicine Certification
Offers certification for physicians who complete the self-study course on parasitic diseases, enhancing clinical readiness for practice in tropical and resource-limited settings.
Weekly Clinical Updates
Curated educational resources on emerging infectious diseases and parasitic infections, distributed to keep medical professionals informed.
activities · 4 groups

What they do

  • Biomedical Research and Innovation 2 activities
    • Authoring and co-authoring authoritative texts and scientific research on parasitic diseases
      Authored or co-authored multiple editions of the textbook "Parasitic Diseases" and more than 500 original scientific papers, along with four single-author books, advancing knowledge in neglected tropical diseases and global health.
    • Product development for neglected tropical disease vaccines
      Leads a product development partnership to create new vaccines targeting hookworm, schistosomiasis, leishmaniasis, Chagas disease, and SARS/MERS, contributing to global health innovation.
  • Healthcare Policy Advocacy 1 activity
    • Advocacy for neglected tropical disease treatment and vaccine acceptance
      Co-founded the Global Network for Neglected Tropical Diseases to expand access to essential medicines for hundreds of millions affected and leads national advocacy efforts in the U.S. to defend vaccines and counter anti-vaccine movements.
  • Disease-Specific Clinical & Patient Education 1 activity
    • Distribution of educational resources on parasitic diseases
      Provides free educational materials, including the textbook "Parasitic Diseases" and other books, to physicians and medical students in the U.S. and globally, with thousands of copies distributed across over 100 countries to address gaps in medical education on eukaryotic parasite diseases.
  • Uncategorized 1 activity
    • Online education and certification in parasitic diseases
      Offers a 45-part video lecture series, a comprehensive e-learning course, and online certification exams in protozoans, nematodes, cestodes, and trematodes based on their textbook to train medical professionals and students in limited-resource settings.
financials · form 990 · fy2023
revenue
Total revenue$136K
Contributions & grants$136K100%
Program service revenue$00%
Investment income$40%
Other revenue$0
expenses
Total expenses$304K
Program expenses88%
Admin / overhead12%
Fundraising0%
Salaries & benefits$0
Grants paid out$60K
Largest expense lineFacilities
balance sheet
Total assets$364K
Cash$202K
Investments$0
Liabilities$147K
Net assets$217K
Liquid reserves8.0 mo
4 years on record · 2020–2023 · YoY revenue -72.0%
leadership · form 990 part vii · fy2023

Who runs it

board members · 5
  • CHARLES KNIRSCH — TREASURER
  • DANIEL GRIFFIN — PRESIDENT
  • DICKSON DESPOMMIER — VICE PRESIDENT
  • PETER HOTEZ — DIRECTOR
  • VINCENT RACANIELLO — SECRETARY
relationships · 28

Who they work with

  • Baylor College of Medicine Partner — Institution where Dr. Hotez serves as Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology.
  • Baylor College of Medicine Partner — Institution where Peter J. Hotez serves as Dean of the National School of Tropical Medicine and collaborates in tropical disease research and education.
  • Clinton Global Initiative Partner — Forum where Dr. Hotez co-founded the Global Network for Neglected Tropical Diseases in 2006.
  • Columbia University Government — Hosts emeritus professorship with appointments in Department of Environmental Health Sciences and Department of Microbiology.
  • Columbia University College of Physicians and Surgeons Partner — Academic affiliate where Dr. Daniel Griffin serves as Clinical Instructor of Medicine
  • Columbia University College of Physicians and Surgeons Partner — Academic institution where Daniel Griffin and Vincent Racaniello hold faculty appointments and contribute to medical education.
  • Floating Doctors Partner — Organization for which Dr. Daniel Griffin has delivered invited lectures on infectious disease topics
  • Foundation for International Medical Relief of Children (FIMRC) Partner — Organization for which Dr. Daniel Griffin has delivered invited lectures on infectious disease topics
  • Foundation for International Medical Relief of Children (FIMRC) Partner — Parasites Without Borders is matching donations to FIMRC during specific months, indicating a collaborative partnership.
  • Global Network for Neglected Tropical Diseases Partner — Co-founded by Dr. Hotez as a partnership initiative to expand access to essential medicines for neglected tropical diseases.
  • OPTUM Partner — Parent company of ProHEALTH, where Daniel Griffin, MD, PhD serves as Chief of the Division of Infectious Disease.
  • Pan American Health Organization Government — Awarded Dr. Hotez the Abraham Horwitz Award for Excellence in Leadership in Inter-American Health in 2011.
  • Peace Corp Partner — Organization for which Dr. Daniel Griffin has delivered invited lectures on infectious disease topics
  • Pfizer Inc. Partner — Dr. Knirsch worked at Pfizer Inc. in various roles over two decades, including Chief Development Officer of Infectious Diseases.
  • ProHEALTH Partner — Hosts Daniel Griffin, MD, PhD, President of Parasites Without Borders, as Chief of the Division of Infectious Disease.
  • ProHEALTH, an OPTUM Company Government — Employer and institutional affiliation of Dr. Daniel Griffin, Chief of Infectious Disease
  • Remote Care Education Partner — Organization for which Dr. Daniel Griffin has delivered invited lectures on infectious disease topics
  • Texas Children’s Hospital Partner — Healthcare institution where Peter J. Hotez serves as Co-Director of the Texas Children’s Center for Vaccine Development.
  • Texas Children’s Hospital Partner — Institution where Dr. Hotez is Director of the Center for Vaccine Development and holds the Endowed Chair of Tropical Pediatrics.
  • The Clinical Trials Transformation Initiative Partner — Dr. Knirsch has worked on pro-competitive initiatives with The Clinical Trials Transformation Initiative.
  • The Foundation of NIH Partner — Dr. Knirsch has worked on pro-competitive initiatives with The Foundation of NIH.
  • The Innovative Medicines Initiative Partner — Dr. Knirsch has participated in pro-competitive initiatives with The Innovative Medicines Initiative.
  • U.S. National Institutes of Health Government — Dr. Knirsch is a member and rotating Chair of the Special Emphasis Study Review section panel.
  • UHG Research and Development Government — Institutional affiliation where Dr. Daniel Griffin serves as Senior Fellow for Infectious Disease
  • UHG Research and Development Partner — Organization where Daniel Griffin, MD, PhD serves as Senior Fellow for Infectious Disease.
  • US State Department Government — Appointed Dr. Hotez to serve on the Board of Governors for the US Israel Binational Science Foundation in 2018.
  • University of Glasgow Partner — Organization for which Dr. Daniel Griffin has delivered invited lectures on infectious disease topics
  • University of Minnesota Partner — Organization for which Dr. Daniel Griffin has delivered invited lectures on infectious disease topics
strategies · 3

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • Education-First Model for Clinical Impact
    methodology: education_first
    By improving access to high-quality, up-to-date medical education on parasitic diseases, the organization enhances clinical knowledge and practice among physicians and medical students, leading to better patient outcomes in underserved populations because informed providers deliver more effective care.
  • Equitable Vaccine Development and Access
    methodology: vaccine_development_and_access_partnership
    By developing vaccines for neglected tropical diseases through product development partnerships, the organization drives innovation while ensuring equitable global access, because integrating access planning into the development process prevents exclusion of low-resource populations.
  • Science Communication via Personal Narrative
    methodology: science_communication_through_personal_narrative
    By combining scientific expertise with personal narrative—such as lived experience as an autism parent—the organization builds public trust in vaccines and counters misinformation, because relatable stories increase message receptivity where data alone fails.